Atrium Therapeutics, Inc. Common StockEigentümerstruktur
| Preis (2026-07-29) | 52W Hoch | 52W Tief |
| 11.18 USD | 16,77 USD | 11,13 USD |
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| 25 USD | 9 | 6 | 0 | 0 | 0 |
| #Shares | Short [%] | Short Ratio |
| 17.105.643 | 6,62 | 14,33 |
Eigentümerstruktur
Analyse der Aktionärsstruktur und institutionellen Investoren
Unternehmensdaten
Grundlegende Informationen
Grunddaten
Name Atrium Therapeutics, Inc. Common Stock
Mitarbeiter 511
Handelsplatz NASDAQ
Ticker Symbol RNA
IPO Datum 2013-06-28
Adresse 10578 Science Center Drive, San Diego, CA, United States, 92121
Webseite https://atriumtherapeutics.com
Unternehmensführung
| Rang | Name | Position |
|---|---|---|
| 1 | Ms. Kathleen P. Gallagher | President, CEO & Director |
| 2 | Mr. Brendan Winslow | Chief Financial Officer |
| 3 | Dr. Husam Younis Ph.D., Pharm.D. | Chief Scientific Officer |
| 4 | Ms. Stephanie Kenney | Chief Corporate Affairs Officer |
| 5 | Dr. Steven George Hughes M.B.A., M.D. | Chief Medical Officer |
| 6 | Ms. Rocio Martin Hoyos | Chief Strategy Officer |
Aktionärsverteilung
Aufteilung der Investoren
Größte Investoren
| Rang | Inhaber | Anteile | Wert |
|---|---|---|---|
| 1 | Vanguard Group Inc | 0,00% | 0,00 Mio. USD |
| 2 | BlackRock Inc | 0,00% | 0,00 Mio. USD |
| 3 | RA Capital Management, LLC | 0,00% | 0,00 Mio. USD |
| 4 | HHG PLC | 0,00% | 0,00 Mio. USD |
| 5 | Balyasny Asset Management LLC | 0,00% | 0,00 Mio. USD |
| 6 | Pentwater Capital Management LP | 0,00% | 0,00 Mio. USD |
| 7 | State Street Corp | 0,00% | 0,00 Mio. USD |
| 8 | The Goldman Sachs Group Inc | 0,00% | 0,00 Mio. USD |
| 9 | UBS O'Connor LLC | 0,00% | 0,00 Mio. USD |
| 10 | Farallon Capital Management, L.L.C. | 0,00% | 0,00 Mio. USD |
| 11 | Geode Capital Management, LLC | 0,00% | 0,00 Mio. USD |
| 12 | NORGES BANK | 0,00% | 0,00 Mio. USD |
| 13 | Bellevue Group AG | 0,00% | 0,00 Mio. USD |
| 14 | Adage Capital Partners Gp LLC | 0,00% | 0,00 Mio. USD |
| 15 | UBS Group AG | 0,00% | 0,00 Mio. USD |
| 16 | Weiss Asset Management LP | 0,00% | 0,00 Mio. USD |
| 17 | Millennium Management LLC | 0,00% | 0,00 Mio. USD |
| 18 | Test Hedge Fund Mgmt | 0,00% | 0,00 Mio. USD |
| 19 | Citadel Advisors Llc | 0,00% | 0,00 Mio. USD |
| 20 | Charles Schwab Investment Management Inc | 0,00% | 0,00 Mio. USD |